Navigation

Gastroenterologi

Evidence-based Management of Lipid Disorders

Udgivet af TFM Publishing Ltd

Bogdetaljer

  • Indbundet
  • 322 sider
  • Engelsk
ISBN 9781903378717
Om denne bog

Practising evidence-based medicine necessarily depends on the clinician having access to the best evidence available, but in a fast-moving field, keeping up to date with the latest developments is a challenging prospect. In this new volume, leading experts focus on the most important clinical issues associated with the…

Se alle bogdetaljer →
Prissammenligning

Ingen boghandelspriser listet endnu

Denne titel er i vores bogkatalog. Butikstilbud vises her, når de er tilgængelige.

Betroet sælger:

Ingen boghandelstilbud lige nu.

Søg efter ISBN
Opdateret i dag

Boghandelspriser

Boghandel Titel Format ISBN Pris Lagerstatus Levering

Ingen boghandelstilbud endnu

Vi har titlen i kataloget. Priser vises her, når boghandlere lister den.

0.0
0 anmeldelser
5
0
4
0
3
0
2
0
1
0
0%
Anbefaler
0
Verificeret
Alle anmeldelser (0)

Ingen anmeldelser endnu

Skriv en anmeldelse

Valgfri - Kun brugt til verifikation
0 / 5000 tegn
Bogdetaljer
Forlag TFM Publishing Ltd
Kategori Gastroenterologi
ISBN-13 9781903378717
EAN 9781903378717
Format Indbundet
Sprog Engelsk
sider 322
Produktbeskrivelse
Practising evidence-based medicine necessarily depends on the clinician having access to the best evidence available, but in a fast-moving field, keeping up to date with the latest developments is a challenging prospect. In this new volume, leading experts focus on the most important clinical issues associated with the management of Lipid Disorders, evaluating and interpreting the evidence available to provide the reader with a reliable summary of our current knowledge. Topics covered include therapeutic strategies for managing hereditary lipid disorders, including familial hypercholesterolaemia, both in adults and children, and familial combined hypercholesterolaemia. The authors also evaluate the evidence for a link between inflammatory disease and cardiovascular risk; the metabolic syndrome and the interconnections between dyslipidaemias and diabetes. They also look at therapeutic challenges such as the management of patients who are statin resistant, and the control of lipid levels in those suffering renal insufficiency. Tables highlight important data, evidence from trial results and expert reports, and each section concludes with a series of Key Points that present a summary of evidence-based recommendations for best practice, graded according to the quality of that evidence. The book provides the busy clinician with a unique analysis of the data supporting current therapies and will help the reader formulate effective strategies for treating their own patients.

Prishistorik

Indlæser prishistorik...

Få prisalarm

Bliv underrettet, når prisen falder til dit ønskede beløb.